VVY.AS

Vivoryon Therapeutics N.V. [VVY.AS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VVY.AS Stock Summary

Top 10 Correlated ETFs

VVY.AS


Top 10 Correlated Stocks

VVY.AS


In the News

VVY.AS Financial details

Company Rating
Neutral
Market Cap
14.11M
Income
-39.86M
Revenue
10.76M
Book val./share
1.6
Cash/share
1.49
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
17 Apr 2024
P/E
0
Forward P/E
-0.89
PEG
-
P/S
-
P/B
-
P/C
0.36
P/FCF
-9.44
Quick Ratio
8.14
Current Ratio
9.4
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-1.74
EPS next Y
-0.61
EPS next Q
-
EPS this Y
103.17%
EPS next Y
-64.92%
EPS next 5Y
-626.71%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-39.71%
-
-
-
-
SMA20
-88.89%
SMA50
-87.5%
SMA100
-87.5%
Inst Own
-
Inst Trans
-
ROA
-90%
ROE
-131%
ROC
-1.04%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
25.89M
Shs Float
19.19M
-
-
-
-
Target Price
-
52W Range
0.49-19.56
52W High
-
52W Low
-
RSI
11
Rel Volume
0.28
Avg Volume
574.01K
Volume
157.96K
Perf Week
0.75%
Perf Month
-94.42%
Perf Quarter
-94.96%
Perf Half Y
-95.29%
-
-
-
-
Beta
1.616
-
-
Volatility
0.01%, 4.02%
Prev Close
2.08%
Price
0.54
Change
-1.1%

VVY.AS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.540
Net income per share
-0.94-0.62-0.83-0.63-1.28
Operating cash flow per share
-0.85-0.92-0.7-0.56-0.99
Free cash flow per share
-0.85-0.93-0.73-0.56-0.99
Cash per share
0.463.311.320.731.21
Book value per share
0.153.41.310.831.2
Tangible book value per share
0.153.41.280.81.18
Share holders equity per share
0.153.41.310.831.2
Interest debt per share
-10.110.040.020.010.01
Market cap
20.6K68.27M179.98M380M227.24M
Enterprise value
16.82K27.15M153.99M365.56M200.82M
P/E ratio
-2.66-8.73-10.9-30.03-8.07
Price to sales ratio
00035.30
POCF ratio
-2.95-5.88-12.84-33.76-10.43
PFCF ratio
-2.94-5.86-12.28-33.67-10.42
P/B Ratio
16.751.66.8622.958.57
PTB ratio
16.751.66.8622.958.57
EV to sales
00033.960
Enterprise value over EBITDA
-2.19-3.53-9.7-28.92-6.93
EV to operating cash flow
-2.4-2.34-10.99-32.47-9.21
EV to free cash flow
-2.4-2.33-10.51-32.39-9.21
Earnings yield
-0.38-0.11-0.09-0.03-0.12
Free cash flow yield
-0.34-0.17-0.08-0.03-0.1
Debt to equity
-67.480.010.010.010
Debt to assets
-20.50.010.010.010
Net debt to EBITDA
0.495.351.641.140.91
Current ratio
4.1348.7921.7349.4
Interest coverage
0-71.98-696.39-533.58-1.21K
Income quality
0.91.480.850.890.77
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0001.620
Intangibles to total assets
000.020.020.02
Capex to operating cash flow
000.0500
Capex to revenue
00000
Capex to depreciation
-0.7-0.53-4.38-0.17-0.08
Stock based compensation to revenue
00000
Graham number
1.786.914.943.435.88
ROIC
0.09-0.18-0.6-0.78-1.08
Return on tangible assets
-1.91-0.17-0.57-0.53-0.91
Graham Net
2.893.091.150.461.12
Working capital
3.02K44.45M27.47M15.18M27.43M
Tangible asset value
1.22K42.65M25.66M16.02M26.01M
Net current asset value
1.16K42.18M25.26M12.27M25.82M
Invested capital
-67.480.010.010.010
Average receivables
68.5K346.5K365.5K1.74M3.66M
Average payables
558655.57252.64K3.45K
Average inventory
-68.5K-45.5K000
Days sales outstanding
000113.940
Days payables outstanding
12.252.242.280.925.77
Days of inventory on hand
-1.44K0000
Receivables turnover
0003.20
Payables turnover
29.79163.27160.26397.7163.31
Inventory turnover
-0.250000
ROE
-6.29-0.18-0.63-0.76-1.06
Capex per share
00-0.0300

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00.54000
Net income per share
-0.58-0.05-0.6-0.68-0.41
Operating cash flow per share
-0.33-0.24-0.49-0.51-0.78
Free cash flow per share
-0.33-0.24-0.49-0.51-0.78
Cash per share
1.030.731.161.161.49
Book value per share
0.770.831.21.161.6
Tangible book value per share
0.750.81.171.141.58
Share holders equity per share
0.770.831.21.161.6
Interest debt per share
0.010.010.010.010
Market cap
359.56M380.96M165.04M236.02M320.37M
Enterprise value
340M366.52M140.83M209.6M290.87M
P/E ratio
-7.7-96.79-3.28-3.79-7.47
Price to sales ratio
035.39000
POCF ratio
-54.98-80.76-16.12-20.42-15.79
PFCF ratio
-54.78-80.83-16.12-20.41-15.79
P/B Ratio
23.2423.016.548.97.71
PTB ratio
23.2423.016.548.97.71
EV to sales
034.05000
Enterprise value over EBITDA
-29.03-393.69-10.59-13.37-27.41
EV to operating cash flow
-51.99-77.7-13.76-18.14-14.34
EV to free cash flow
-51.8-77.77-13.75-18.12-14.33
Earnings yield
-0.030-0.08-0.07-0.03
Free cash flow yield
-0.02-0.01-0.06-0.05-0.06
Debt to equity
0.020.010.0100
Debt to assets
0.010.010.0100
Net debt to EBITDA
1.6715.511.821.692.78
Current ratio
4.247.079.419.45
Interest coverage
-1.47K-63.31-1.22K-1.21K-411.23
Income quality
0.564.790.810.741.89
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00.74000
Intangibles to total assets
0.020.020.020.020.01
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
-0.290.05-0.02-0.11-0.11
Stock based compensation to revenue
00000
Graham number
3.190.954.024.213.85
ROIC
-0.74-0.11-0.53-0.58-0.26
Return on tangible assets
-0.52-0.04-0.4-0.5-0.24
Graham Net
0.690.4611.081.45
Working capital
16.86M15.18M26.61M27.43M42.44M
Tangible asset value
14.92M16.02M24.73M26.01M41.06M
Net current asset value
14.56M12.27M24.48M25.82M40.92M
Invested capital
0.020.010.0100
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
028.09000
Days payables outstanding
5.410.244.092.861.47
Days of inventory on hand
00000
Receivables turnover
03.2000
Payables turnover
16.64378.672231.4661.19
Inventory turnover
83K0000
ROE
-0.75-0.06-0.5-0.59-0.26
Capex per share
00000

VVY.AS Frequently Asked Questions

What is Vivoryon Therapeutics N.V. stock symbol ?

Vivoryon Therapeutics N.V. is a DE stock and trading under the symbol VVY.AS

What is Vivoryon Therapeutics N.V. stock quote today ?

Vivoryon Therapeutics N.V. stock price is $0.54 today.

Is Vivoryon Therapeutics N.V. stock public?

Yes, Vivoryon Therapeutics N.V. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap